(Q34534058)

2 August 2017

1 reference

title

Tenofovir disoproxil fumarate. (English)

1 reference

2 August 2017

1 reference

Shellee A Grim

1

1 reference

PubMed ID

12773076

2 August 2017

Frank Romanelli

series ordinal

2

1 reference

PubMed ID

12773076

2 August 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

Annals of Pharmacotherapy

2 August 2017

1 reference

2 August 2017

37

1 reference

2 August 2017

6

1 reference

2 August 2017

849-859

1 reference

Decline in deaths from AIDS due to new antiretrovirals

2 August 2017

1 reference

Selective inhibition of HIV-1 reverse transcriptase by an antiviral inhibitor, (R)-9-(2-Phosphonylmethoxypropyl)adenine

21 January 2018

1 reference

Tenofovir (PMPA) is less susceptible to pyrophosphorolysis and nucleotide-dependent chain-terminator removal than zidovudine or stavudine

21 January 2018

1 reference

Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

21 January 2018

1 reference

Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cells

21 January 2018

1 reference

The genetic variability of HIV-1 and its implications

21 January 2018

1 reference

Tenofovir, adefovir, and zidovudine susceptibilities of primary human immunodeficiency virus type 1 isolates with non-B subtypes or nucleoside resistance

21 January 2018

1 reference

Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults

21 January 2018

1 reference

Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study

21 January 2018

1 reference

Impact of immune interventions on proviral HIV-1 DNA decay in patients receiving highly active antiretroviral therapy

21 January 2018

1 reference

Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacy

21 January 2018

1 reference

Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L-FMAU, DAPD, penciclovir and lobucavir

21 January 2018

1 reference

Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication

21 January 2018

1 reference

Fetal and maternal outcome after administration of tenofovir to gravid rhesus monkeys (Macaca mulatta).

21 January 2018

1 reference

Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infection

21 January 2018

1 reference

Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection

21 January 2018

1 reference

Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques

21 January 2018

1 reference

Genotypic and phenotypic analyses of HIV-1 in antiretroviral-experienced patients treated with tenofovir DF.

21 January 2018

1 reference

The impact of the M184V substitution in HIV-1 reverse transcriptase on treatment response

21 January 2018

1 reference

Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA.

21 January 2018

1 reference

Phenotypic susceptibilities to tenofovir in a large panel of clinically derived human immunodeficiency virus type 1 isolates.

21 January 2018

1 reference

Antiviral activity of tenofovir (PMPA) against nucleoside-resistant clinical HIV samples

21 January 2018

1 reference

Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R+M184V and their effects on enzyme function and viral replication capacity

21 January 2018

1 reference

ATP-dependent removal of nucleoside reverse transcriptase inhibitors by human immunodeficiency virus type 1 reverse transcriptase

21 January 2018

1 reference

Adefovir and tenofovir susceptibilities of HIV-1 after 24 to 48 weeks of adefovir dipivoxil therapy: genotypic and phenotypic analyses of study GS-96-408.

21 January 2018

1 reference

Metabolic pathways for activation of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine in human lymphoid cells

21 January 2018

1 reference

Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs

21 January 2018

1 reference

Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir

21 January 2018

1 reference

Metabolism and pharmacokinetics of novel oral prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs

21 January 2018

1 reference

Intestinal absorption enhancement of the ester prodrug tenofovir disoproxil fumarate through modulation of the biochemical barrier by defined ester mixtures.

21 January 2018

1 reference

Synthesis and evaluation of novel amidate prodrugs of PMEA and PMPA.

21 January 2018

1 reference

Mitochondrial toxicity of antiviral drugs

21 January 2018

1 reference

Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity.

21 January 2018

1 reference

Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors.

21 January 2018

1 reference

Hydroxyurea does not enhance the anti-HIV activity of low-dose tenofovir disoproxil fumarate

21 January 2018

1 reference

Barriers to adherence to highly active antiretroviral therapy as expressed by people living with HIV/AIDS.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1C388

1 reference

2 August 2017

1 reference

PubMed ID

12773076